Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
234 rows where has_cryoEM = 0, surface_class = "A_assoc" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
tier 1
- Tier 1.5 · 234 ✖
surface_class 1
- A_assoc · 234 ✖
has_cryoEM 1
- - · 234 ✖
has_activation_state_pdb_pair 1
- 0 234
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P02462 | COL4A1 | Collagen alpha-1(IV) chain | Tier 1.5 | 0.854 | 1 | A_assoc | 4 | 48.47 | 0 | 0 | 0 | 0 | 1 | brain small vessel disease 1 with or without ocular anomalies | 0.84655287380359 | |||
| P22105 | TNXB | Tenascin-X | Tier 1.5 | 0.837 | 1 | A_assoc | 3 | 87.81 | 0 | 0 | 0 | 0 | 1 | Ehlers-Danlos syndrome due to tenascin-X deficiency | 0.7916412481554758 | |||
| P35625 | TIMP3 | Metalloproteinase inhibitor 3 | Tier 1.5 | 0.831 | 1 | A_assoc | 1 | 87.0 | 0 | 0 | 1 | 3 | 42105605, 36768220 | 1 | Sorsby fundus dystrophy | 0.7684253675298044 | ||
| P08572 | COL4A2 | Collagen alpha-2(IV) chain | Tier 1.5 | 0.819 | 1 | A_assoc | 4 | 47.25 | 0 | 0 | 0 | 0 | 1 | porencephaly 2 | 0.7294975109351518 | |||
| P36955 | SERPINF1 | Pigment epithelium-derived factor | Tier 1.5 | 0.811 | 1 | A_assoc | 3 | 90.12 | 0 | 0 | 1 | 17 | 41503480, 40965986, 24311895, 21546514, 19668729, 17628122, 16787141, 16724865, 16136393, 15947805 | 1 | osteogenesis imperfecta | 0.701995723393119 | ||
| O00187 | MASP2 | Mannan-binding lectin serine protease 2 | Tier 1.5 | 0.81 | 1 | A_assoc | 10 | 89.44 | 0 | 0 | 1 | 1 | 40371468 | 1 | immunodeficiency due to MASP-2 deficiency | 0.6996393077218865 | ||
| Q9Y6C2 | EMILIN1 | EMILIN-1 | Tier 1.5 | 0.786 | 1 | A_assoc | 2 | 62.91 | 0 | 0 | 0 | 0 | 1 | arterial tortuosity-bone fragility syndrome | 0.6185329512431467 | |||
| P49767 | VEGFC | Vascular endothelial growth factor C | Tier 1.5 | 0.785 | 1 | A_assoc | 4 | 73.19 | 0 | 0 | 0 | 0 | 1 | Milroy disease | 0.6170524106764851 | |||
| Q16270 | IGFBP7 | Insulin-like growth factor-binding protein 7 | Tier 1.5 | 0.785 | 1 | A_assoc | 1 | 84.44 | 0 | 0 | 1 | 4 | 41192243, 27679852, 41280530 | 1 | familial retinal arterial macroaneurysm | 0.6182241349863704 | ||
| P10451 | SPP1 | Osteopontin | Tier 1.5 | 0.772 | 1 | A_assoc | 3 | 53.41 | 0 | 0 | 1 | 62 | 41690559, 41223977, 39422353, 38600327, 32943056, 32042311, 31603904, 30307407, 28916037, 28453726, 25278703, 21147843, 42136308, 42108056, 40845664, 40479828, 39677448, 39340832, 38834269, 37162508, 36508319, 36284815, 35433114, 35190123, 34420232, 32166466, 31987218, 31879964, 31806966, 31301870, 30135425, 29441346, 28988933, 28706912, 26529285, 25949891, 25930003, 25713073, 24902765, 24491763, 24438228, 23889968, 23619316, 22880609, 22241292, 21962803, 21801960, 20967826, 19570203, 18985031 | 1 | osteoporosis | 0.5729473764531288 | ||
| P10909 | CLU | Clusterin | Tier 1.5 | 0.766 | 1 | A_assoc | 2 | 77.31 | 0 | 0 | 1 | 5 | 42041411, 37179603, 36980195, 35383192, 26061649 | 1 | Alzheimer disease | 0.5545645077431476 | ||
| P13497 | BMP1 | Bone morphogenetic protein 1 | Tier 1.5 | 0.766 | 1 | A_assoc | 8 | 81.44 | 0 | 0 | 1 | 1 | 39939919 | 1 | osteogenesis imperfecta | 0.5547577676549571 | ||
| O00622 | CCN1 | CCN family member 1 | Tier 1.5 | 0.765 | 1 | A_assoc | 2 | 73.12 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.5505331194769112 | |||
| Q68CZ2 | TNS3 | Tensin-3 | Tier 1.5 | 0.762 | 1 | A_assoc | 1 | 56.81 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.539772721274482 | |||
| P55145 | MANF | Mesencephalic astrocyte-derived neurotrophic factor | Tier 1.5 | 0.761 | 1 | A_assoc | 3 | 81.69 | 0 | 0 | 1 | 1 | 12698297 | 1 | diabetes, deafness, developmental delay, and short stature syndrome | 0.5377386885662411 | ||
| Q9Y3B8 | REXO2 | Oligoribonuclease, mitochondrial | Tier 1.5 | 0.754 | 1 | A_assoc | 10 | 88.19 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5134178677464454 | |||
| P36980 | CFHR2 | Complement factor H-related protein 2 | Tier 1.5 | 0.753 | 1 | A_assoc | 4 | 90.62 | 0 | 0 | 0 | 0 | 1 | age-related macular degeneration | 0.5100732932209376 | |||
| Q13177 | PAK2 | Serine/threonine-protein kinase PAK 2 | Tier 1.5 | 0.736 | 1 | A_assoc | 5 | 74.62 | 0 | 0 | 0 | 0 | 1 | Knobloch syndrome | 0.45371318009439854 | |||
| Q13625 | TP53BP2 | Apoptosis-stimulating of p53 protein 2 | Tier 1.5 | 0.735 | 1 | A_assoc | 6 | 58.97 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.4484066399496438 | |||
| Q9UKU9 | ANGPTL2 | Angiopoietin-related protein 2 | Tier 1.5 | 0.727 | 1 | A_assoc | 1 | 78.19 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.4235882639081519 | |||
| Q96SL4 | GPX7 | Glutathione peroxidase 7 | Tier 1.5 | 0.721 | 1 | A_assoc | 1 | 92.69 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.40349356855524837 | |||
| Q16627 | CCL14 | C-C motif chemokine 14 | Tier 1.5 | 0.711 | 1 | A_assoc | 2 | 85.38 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.37013422446672883 | |||
| P22692 | IGFBP4 | Insulin-like growth factor-binding protein 4 | Tier 1.5 | 0.706 | 1 | A_assoc | 4 | 77.25 | 0 | 0 | 1 | 6 | 35323639, 32515246, 31930684 | 1 | allergic rhinitis | 0.35214760515440524 | ||
| P12273 | PIP | Prolactin-inducible protein | Tier 1.5 | 0.701 | 1 | A_assoc | 1 | 89.69 | 0 | 0 | 1 | 7 | 41440247, 36179084, 35726753, 35336001, 28107930, 26297462, 21559755 | 1 | neurodegenerative disease | 0.3382059336442212 | ||
| P98066 | TNFAIP6 | Tumor necrosis factor-inducible gene 6 protein | Tier 1.5 | 0.693 | 1 | A_assoc | 5 | 81.12 | 0 | 0 | 1 | 1 | 39263947 | 1 | type 2 diabetes mellitus | 0.30862220597837015 | ||
| Q8WUP2 | FBLIM1 | Filamin-binding LIM protein 1 | Tier 1.5 | 0.687 | 1 | A_assoc | 3 | 66.44 | 0 | 0 | 0 | 0 | 1 | COVID-19 | 0.28975781420803737 | |||
| Q13253 | NOG | Noggin | Tier 1.5 | 0.685 | 1 | A_assoc | 2 | 86.06 | 0 | 0 | 1 | 2 | 38397086 | 0 | proximal symphalangism 1A | 0.7844136456463046 | ||
| P01138 | NGF | Beta-nerve growth factor | Tier 1.5 | 0.684 | 1 | A_assoc | 8 | 73.25 | 0 | 0 | 1 | 6 | 42015870, 38780008, 32982626, 21216401, 7545283, 29754498 | 0 | hereditary sensory and autonomic neuropathy type 5 | 0.7785402119369383 | ||
| P18510 | IL1RN | Interleukin-1 receptor antagonist protein | Tier 1.5 | 0.682 | 1 | A_assoc | 5 | 87.06 | 0 | 0 | 1 | 1 | 38928037 | 0 | sterile multifocal osteomyelitis with periostitis and pustulosis | 0.7734282711738736 | ||
| P29120 | PCSK1 | Neuroendocrine convertase 1 | Tier 1.5 | 0.682 | 1 | A_assoc | 3 | 82.5 | 0 | 0 | 0 | 0 | 0 | obesity due to prohormone convertase I deficiency | 0.773875795833803 | |||
| P16112 | ACAN | Aggrecan core protein | Tier 1.5 | 0.677 | 1 | A_assoc | 4 | 51.91 | 0 | 0 | 0 | 0 | 0 | Familial osteochondritis dissecans | 0.7558487616449627 | |||
| P55789 | GFER | FAD-linked sulfhydryl oxidase ALR | Tier 1.5 | 0.677 | 1 | A_assoc | 7 | 76.88 | 0 | 0 | 0 | 0 | 0 | congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome | 0.7556346526616893 | |||
| Q12794 | HYAL1 | Hyaluronidase-1 | Tier 1.5 | 0.672 | 1 | A_assoc | 1 | 94.0 | 0 | 0 | 0 | 0 | 0 | Hyaluronidase deficiency | 0.7412407206736383 | |||
| Q92752 | TNR | Tenascin-R | Tier 1.5 | 0.672 | 1 | A_assoc | 2 | 78.5 | 0 | 0 | 0 | 0 | 0 | neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus | 0.7403484347367364 | |||
| O15520 | FGF10 | Fibroblast growth factor 10 | Tier 1.5 | 0.67 | 1 | A_assoc | 2 | 80.0 | 0 | 0 | 1 | 1 | 35415885 | 0 | Lacrimoauriculodentodigital syndrome | 0.7344198619465704 | ||
| O00300 | TNFRSF11B | Tumor necrosis factor receptor superfamily member 11B | Tier 1.5 | 0.666 | 1 | A_assoc | 1 | 86.5 | 0 | 0 | 1 | 1 | 15562003 | 0 | juvenile Paget disease | 0.7184894548525037 | ||
| P11686 | SFTPC | Surfactant protein C | Tier 1.5 | 0.663 | 1 | A_assoc | 3 | 70.06 | 0 | 0 | 0 | 0 | 0 | Congenital pulmonary alveolar proteinosis | 0.7110128683619542 | |||
| O43897 | TLL1 | Tier 1.5 | 0.662 | 1 | A_assoc | 1 | 80.31 | 0 | 0 | 0 | 0 | 0 | atrial heart septal defect | 0.7050140477090344 | ||||
| P19835 | CEL | Bile salt-activated lipase | Tier 1.5 | 0.658 | 1 | A_assoc | 7 | 82.56 | 0 | 0 | 1 | 2 | 39653009, 34940276 | 0 | MODY | 0.6940743944678538 | ||
| P27352 | CBLIF | Cobalamin binding intrinsic factor | Tier 1.5 | 0.655 | 1 | A_assoc | 2 | 90.5 | 0 | 0 | 0 | 0 | 0 | hereditary intrinsic factor deficiency | 0.683930100359911 | |||
| Q9Y5C1 | ANGPTL3 | Angiopoietin-related protein 3 | Tier 1.5 | 0.652 | 1 | A_assoc | 1 | 79.62 | 0 | 0 | 1 | 1 | 23770039 | 0 | familial hypobetalipoproteinemia 2 | 0.6739043862507132 | ||
| O75594 | PGLYRP1 | Peptidoglycan recognition protein 1 | Tier 1.5 | 0.649 | 1 | A_assoc | 1 | 91.0 | 0 | 0 | 1 | 2 | 35821507, 33534888 | 1 | dementia | 0.16478389504231422 | ||
| P02776 | PF4 | Platelet factor 4 | Tier 1.5 | 0.635 | 1 | A_assoc | 10 | 75.06 | 0 | 0 | 1 | 10 | 33859620, 32366845, 31967847, 23847186, 23673861, 34248840, 32022468 | 1 | systemic scleroderma | 0.11523541376593864 | ||
| O76093 | FGF18 | Fibroblast growth factor 18 | Tier 1.5 | 0.631 | 1 | A_assoc | 1 | 87.56 | 0 | 0 | 1 | 1 | 35415885 | 0 | cancer | 0.6028027301556572 | ||
| P08620 | FGF4 | Fibroblast growth factor 4 | Tier 1.5 | 0.631 | 1 | A_assoc | 1 | 81.5 | 0 | 0 | 1 | 3 | 35415885, 33536494, 7547864 | 0 | cancer | 0.6026669167438079 | ||
| O95445 | APOM | Apolipoprotein M | Tier 1.5 | 0.631 | 1 | A_assoc | 3 | 89.44 | 0 | 0 | 1 | 10 | 38238732, 36980195, 35120890, 32237898, 30771967, 37425696, 37400771, 34796696 | 1 | type 2 diabetes mellitus | 0.10169659060091507 | ||
| Q15818 | NPTX1 | Neuronal pentraxin-1 | Tier 1.5 | 0.628 | 1 | A_assoc | 1 | 75.75 | 0 | 0 | 0 | 0 | 0 | spinocerebellar ataxia 50 | 0.5937598292127286 | |||
| P07098 | LIPF | Gastric triacylglycerol lipase | Tier 1.5 | 0.626 | 1 | A_assoc | 1 | 89.75 | 0 | 0 | 0 | 0 | 0 | obesity | 0.5864662753480862 | |||
| Q9GZX6 | IL22 | Interleukin-22 | Tier 1.5 | 0.619 | 1 | A_assoc | 6 | 88.12 | 0 | 0 | 1 | 7 | 34208021, 33869115, 28942363, 26792955, 37041650 | 0 | atopic eczema | 0.5627493881195745 | ||
| O00175 | CCL24 | C-C motif chemokine 24 | Tier 1.5 | 0.613 | 1 | A_assoc | 2 | 82.12 | 0 | 0 | 0 | 0 | 0 | Iron deficiency anemia | 0.5428194908352497 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;